Skip to main content

Available Courses

A Review of Emerging ARNI Data in HFrEF
  • 1.00 EBAC

Learning objectives

  • Review updated data of ARNI therapy for HFrEF present at the ESC 2019;
  • understand the current utilisation of ARNI therapy in HFrEF (guidelines and databases);
  • interpret potential mechanistic data related to the clinical benefit of ARNI therapy including imaging and biomarker data;
  • apply new data covering the utilization of ARNI therapy in complex patients including recently decompensated and hospitalized; patients
  • Apply clinical and real-world evidence data for the treatment HFrEF with ARNI therapy.
See more
ADVANCES IN IMAGING: OPTIMISING MR AND CT IN DAILY PRACTICE
  • 2.00 EBAC

Learning objectives

  • Interpret existing clinical and meta data for use of pre-procedural, image-aided ablation in ventricular arrhythmias
  • Identify where pre-procedural imaging may complement the current ablation workflow in ventricular arrhythmias
  • Recall the clinical benefits of quantitative, MRI-based approaches to evaluate ischaemia
  • Apply quantitative CMR imaging to complement existing procedural workflows in revascularisation procedures
See more
Convergent Procedure for Atrial Fibrillation
  • 1.00 EBAC

Learning objectives

  • Discuss the need for optimal approaches to atrial ablation and identify patients for whom a convergent procedure approach is indicated
  • Describe the convergent procedure and the role of electrophysiologist and surgeon
  • Discuss current clinical understanding of the convergent procedure including emerging data and the role of the left atrial appendage in ablation
See more
Convergent procedure: A new approach to atrial fibrillation ablation
  • 1.00 EBAC

Learning objectives

  • After this session electrophysiologists will be able to identify the causes of sub-optimal outcomes in atrial ablation, describe the convergent procedure and appropriate patients, and outline the electrophysiologist’s role.
See more
Current and Emerging Data on SGLT2 Inhibitors in Heart Failure
  • 1.00 EBAC

Learning objectives

  • Understand the SGLT2 inhibitor cardiovascular outcome trial (CVOT) data;
  • differentiate the latest guideline updates for the treatment of T2D and their recommendations regarding the importance of considering comorbidities, including atherosclerotic cardiovascular disease (ASCVD) and heart failure (HF);
  • apply clinical and real-world evidence of the SGLT2 inhibitor class for use in prevention of hospitalisation in HF, as well as future ongoing studies in the treatment of HF;
  • assess the interrelationships linking diabetes, HF and CVD;
  • interpret the potential cardio-renal mechanisms of the SGLT2 inhibitor class in reducing the risk of CV, including HF. Evaluate emerging data of the treatment of HF with SGLT2 inhibitors in patients with or without T2DM.
See more
Dual antiplatelet therapy for acute stroke and TIA
  • 1.00 EBAC

Learning objectives

  • To highlight the continued high unmet need for strategies to prevent stroke or death for patients experiencing acute stroke or TIA
  • To outline the guidelines on the use of dual antiplatelet therapy for patients presenting with acute stroke or TIA
  • To examine recent evidence from clinical trials on novel strategies for improving outcomes for patients presenting with acute stroke or TIA and how these data and insights can be applied in clinical practice
See more
Getting it Right First Time in Severe Aortic Stenosis - Key insights for Long Term Success
  • 1 EBAC

Learning objectives

  • Recall current and predicted trends in TAVI with respect to preserving coronary access
  • Consider determining factors for choosing valves in low risk populations
  • Discuss solutions for maximising valve durability and haemodynamics and for treating degenerated TAVI
See more
Heart Failure & Cardiomyopathy: Highlights 2019-2021
  • 0.25 AMA PRA Category 1 Credit™

Learning objectives

  • Recall the efficacy and safety of existing HCM treatments
  • Summarize results from ongoing trials with experimental treatments for HFrEF and HCM
See more

Most Recent

View All
Transcatheter Edge-to-Edge Repair: An Assessment of its Long-term Impact on Mitral Regurgitation
  • 1.00 EBAC

Learning objectives

  • Recall the long-term outcomes of TEER from real-world and RCT data
  • Apply the results of real-world data to both simple and complex patients
  • Describe how TEER is being used to benefit a range of patients with MR
See more
HCM in Review: Assessing SCD Risk in HCM & Managing HCM With High Risk SCD
  • 0.50 AMA PRA Credit

Learning objectives

  • Recall risk factors associated with sudden cardiac death (SCD)
  • Recall best practice approaches to prevent SCD according to guidelines and expert insight
  • Stratify patients likely to benefit from invasive procedures versus pharmacological treatment
See more